Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406692 · ClinicalTrials.gov registry record · Phase 2
The Effects of Zonisamide on Alcohol Dependence
A Phase 2 study, sponsored by Boston University.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00406692 is a Phase 2 study that has completed, run by Boston University. The registered enrollment target is 16 participants.
The verdict
NCT00406692, a Phase 2 study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
In this study the influence of zonisamide administration over a 13 week period on alcohol consumption in alcoholic (alcohol dependent) subjects will be examined. The dose of zonisamide given to subjects will be slowly increased over a period of several weeks. They will receive a full dose over a 5 week period. This will be a pilot study in which all of the subjects will only receive zonisamide. A primary objective of this study is to determine the possible size of the effect that zonisamide administration has on drinking (i.e. drinks consumed per day) to allow us to plan for a larger clinical trial of the effects of zonisamide on alcohol dependence.
Interventions
- DRUG Zonisamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00406692
The ClinicalTrials.gov registry entry for NCT00406692 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zonisamide is the first listed.
NCT00406692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00406692 about?
NCT00406692 is a clinical study titled "The Effects of Zonisamide on Alcohol Dependence". In this study the influence of zonisamide administration over a 13 week period on alcohol consumption in alcoholic (alcohol dependent) subjects will be examined. The dose of zonisamide given to subjects will be slowly increased over a period of several weeks. They will receive a full dose over a 5 w...
What is the current status of trial NCT00406692?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2006-11. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00406692?
The interventions under investigation include: Zonisamide (DRUG).
Who is sponsoring clinical trial NCT00406692?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.